CAS: 847499-27-8 - Delanzomib

Formel: C₂₁H₂₈BN₃O₅

InChl: InChI=1S/C21H28BN3O5/c1-13(2)12-18(22(29)30)24-21(28)19(14(3)26)25-20(27)17-11-7-10-16(23-17)15-8-5-4-6-9-15/h4-11,13-14,18-19,26,29-30H,12H2,1-3H3,(H,24,28)(H,25,27)/t14-,18+,19+/m1/s1

InChI Key: InChIKey=SJFBTAPEPRWNKH-CCKFTAQKSA-N

SMILES: O=C(NC(C(=O)NC(B(O)O)CC(C)C)C(O)C)C=1N=C(C=CC1)C=2C=CC=CC2

[(1R)-1-[[(2S,3R)-3-Hydroxy-2-[[(6-phenylpyridin-2-yl)carbonyl]amino]-1-oxobutyl]amino]-3-methylbutyl]boronic acid

CAS: 847499-27-8

• Formel: C₂₁H₂₈BN₃O₅
• Reinheit: 97%
• Farbe und Form: Solid
• Molekulargewicht: 413.2751

Delanzomib [CEP-18770]

CAS: 847499-27-8

Delanzomib

CAS: 847499-27-8

Delanzomib (CEP-18770) is an oral proteasome inhibitor with an IC50 of 3.8 nM, targeting chymotrypsin-like …

• Formel: C₂₁H₂₈BN₃O₅
• Reinheit: 95.52% - 99.46%
• Farbe und Form: Solid
• Molekulargewicht: 413.28

Delanzomib

CAS: 847499-27-8

Stability Hygroscopic Applications Delanzomib is an orally active proteasome inhibitor. Delanzomib has been shown to …

• Formel: C₂₁H₂₈BN₃O₅
• Farbe und Form: Neat
• Molekulargewicht: 413.28

((R)-1-((2S,3R)-3-Hydroxy-2-(6-phenylpicolinamido)butanamido)-3-methylbutyl)boronic acid

CAS: 847499-27-8

((R)-1-((2S,3R)-3-Hydroxy-2-(6-phenylpicolinamido)butanamido)-3-methylbutyl)boronic acid is a cyclic peptide that has been shown to have pro-apoptotic properties. It …

• Formel: C₂₁H₂₈BN₃O₅
• Reinheit: Min. 95%
• Molekulargewicht: 413.28 g/mol